class b cpg oligonucleotide odn2006 Search Results


93
Miltenyi Biotec class b cpg odn 2006 cpg b
Class B Cpg Odn 2006 Cpg B, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/class+b+cpg+oligonucleotide+odn2006/ODN+2006/pmc07332672-23-12-30
Average 93 stars, based on 1 article reviews
class b cpg odn 2006 cpg b - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

97
InvivoGen class b cpg oligonucleotide odn2006
Inhibition of TLR2‐dependent NF‐κB activation and IL‐8 secretion. A) HEK‐Blue hTLR2 cells were pre‐incubated with CU‐CPT22 or compounds 1 – 6 and 9 – 11 for 1 h and then stimulated additionally with TLR2/1 agonist Pam 3 CSK 4 (10 ng/mL) or TLR2/6 agonist Pam 2 CSK 4 (1 ng/mL) for 24 h. B) HEK‐Blue hTLR2 cells were pre‐incubated with increasing concentrations of 4 , 6 , 9 , 10 and then stimulated additionally with Pam 3 CSK 4 or Pam 2 CSK 4 for 24 h. Supernatants were tested for TLR2‐mediated NF‐κB/AP‐1 activity by quantification of SEAP release (OD 640 ). C) THP‐1 macrophages were incubated with CU‐CPT22 (25 μM) or compound 6 for 1 h and afterwards stimulated with Pam 3 CSK 4 (10 ng/mL), Pam 2 CSK 4 (1ng/mL), LPS (10 ng/mL), flagellin (1 μg/mL), CL075 (8 μM) or <t>ODN2006</t> (5 μM) for 24 h. Supernatants were analyzed for IL‐8 secretion by ELISA. Mean+SD or ±SD ( n =3).
Class B Cpg Oligonucleotide Odn2006, supplied by InvivoGen, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/class+b+cpg+oligonucleotide+odn2006/ODN+2006/pmc07496872-177-32-40
Average 97 stars, based on 1 article reviews
class b cpg oligonucleotide odn2006 - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

90
Midland Certified Reagent class b cpg oligodeoxynucleotides odn-2006
Inhibition of TLR2‐dependent NF‐κB activation and IL‐8 secretion. A) HEK‐Blue hTLR2 cells were pre‐incubated with CU‐CPT22 or compounds 1 – 6 and 9 – 11 for 1 h and then stimulated additionally with TLR2/1 agonist Pam 3 CSK 4 (10 ng/mL) or TLR2/6 agonist Pam 2 CSK 4 (1 ng/mL) for 24 h. B) HEK‐Blue hTLR2 cells were pre‐incubated with increasing concentrations of 4 , 6 , 9 , 10 and then stimulated additionally with Pam 3 CSK 4 or Pam 2 CSK 4 for 24 h. Supernatants were tested for TLR2‐mediated NF‐κB/AP‐1 activity by quantification of SEAP release (OD 640 ). C) THP‐1 macrophages were incubated with CU‐CPT22 (25 μM) or compound 6 for 1 h and afterwards stimulated with Pam 3 CSK 4 (10 ng/mL), Pam 2 CSK 4 (1ng/mL), LPS (10 ng/mL), flagellin (1 μg/mL), CL075 (8 μM) or <t>ODN2006</t> (5 μM) for 24 h. Supernatants were analyzed for IL‐8 secretion by ELISA. Mean+SD or ±SD ( n =3).
Class B Cpg Oligodeoxynucleotides Odn 2006, supplied by Midland Certified Reagent, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/class+b+cpg+oligonucleotide+odn2006/class+b+cpg+oligodeoxynucleotides+odn+2006/pm17785797-52-2-23
Average 90 stars, based on 1 article reviews
class b cpg oligodeoxynucleotides odn-2006 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
LabForce AG class b cpg odn 2006
Inhibition of TLR2‐dependent NF‐κB activation and IL‐8 secretion. A) HEK‐Blue hTLR2 cells were pre‐incubated with CU‐CPT22 or compounds 1 – 6 and 9 – 11 for 1 h and then stimulated additionally with TLR2/1 agonist Pam 3 CSK 4 (10 ng/mL) or TLR2/6 agonist Pam 2 CSK 4 (1 ng/mL) for 24 h. B) HEK‐Blue hTLR2 cells were pre‐incubated with increasing concentrations of 4 , 6 , 9 , 10 and then stimulated additionally with Pam 3 CSK 4 or Pam 2 CSK 4 for 24 h. Supernatants were tested for TLR2‐mediated NF‐κB/AP‐1 activity by quantification of SEAP release (OD 640 ). C) THP‐1 macrophages were incubated with CU‐CPT22 (25 μM) or compound 6 for 1 h and afterwards stimulated with Pam 3 CSK 4 (10 ng/mL), Pam 2 CSK 4 (1ng/mL), LPS (10 ng/mL), flagellin (1 μg/mL), CL075 (8 μM) or <t>ODN2006</t> (5 μM) for 24 h. Supernatants were analyzed for IL‐8 secretion by ELISA. Mean+SD or ±SD ( n =3).
Class B Cpg Odn 2006, supplied by LabForce AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/class+b+cpg+oligonucleotide+odn2006/class+b+cpg+odn+2006/pmc12174074-98-23-28
Average 90 stars, based on 1 article reviews
class b cpg odn 2006 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
TIB MOLBIOL nuclease resistant phosphorothioate odn2006
Inhibition of TLR2‐dependent NF‐κB activation and IL‐8 secretion. A) HEK‐Blue hTLR2 cells were pre‐incubated with CU‐CPT22 or compounds 1 – 6 and 9 – 11 for 1 h and then stimulated additionally with TLR2/1 agonist Pam 3 CSK 4 (10 ng/mL) or TLR2/6 agonist Pam 2 CSK 4 (1 ng/mL) for 24 h. B) HEK‐Blue hTLR2 cells were pre‐incubated with increasing concentrations of 4 , 6 , 9 , 10 and then stimulated additionally with Pam 3 CSK 4 or Pam 2 CSK 4 for 24 h. Supernatants were tested for TLR2‐mediated NF‐κB/AP‐1 activity by quantification of SEAP release (OD 640 ). C) THP‐1 macrophages were incubated with CU‐CPT22 (25 μM) or compound 6 for 1 h and afterwards stimulated with Pam 3 CSK 4 (10 ng/mL), Pam 2 CSK 4 (1ng/mL), LPS (10 ng/mL), flagellin (1 μg/mL), CL075 (8 μM) or <t>ODN2006</t> (5 μM) for 24 h. Supernatants were analyzed for IL‐8 secretion by ELISA. Mean+SD or ±SD ( n =3).
Nuclease Resistant Phosphorothioate Odn2006, supplied by TIB MOLBIOL, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/class+b+cpg+oligonucleotide+odn2006/cpg+odn+1826/pm18977183-49-20-30
Average 90 stars, based on 1 article reviews
nuclease resistant phosphorothioate odn2006 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Inhibition of TLR2‐dependent NF‐κB activation and IL‐8 secretion. A) HEK‐Blue hTLR2 cells were pre‐incubated with CU‐CPT22 or compounds 1 – 6 and 9 – 11 for 1 h and then stimulated additionally with TLR2/1 agonist Pam 3 CSK 4 (10 ng/mL) or TLR2/6 agonist Pam 2 CSK 4 (1 ng/mL) for 24 h. B) HEK‐Blue hTLR2 cells were pre‐incubated with increasing concentrations of 4 , 6 , 9 , 10 and then stimulated additionally with Pam 3 CSK 4 or Pam 2 CSK 4 for 24 h. Supernatants were tested for TLR2‐mediated NF‐κB/AP‐1 activity by quantification of SEAP release (OD 640 ). C) THP‐1 macrophages were incubated with CU‐CPT22 (25 μM) or compound 6 for 1 h and afterwards stimulated with Pam 3 CSK 4 (10 ng/mL), Pam 2 CSK 4 (1ng/mL), LPS (10 ng/mL), flagellin (1 μg/mL), CL075 (8 μM) or ODN2006 (5 μM) for 24 h. Supernatants were analyzed for IL‐8 secretion by ELISA. Mean+SD or ±SD ( n =3).

Journal: Chemmedchem

Article Title: Biological Characterization, Mechanistic Investigation and Structure‐Activity Relationships of Chemically Stable TLR2 Antagonists

doi: 10.1002/cmdc.202000060

Figure Lengend Snippet: Inhibition of TLR2‐dependent NF‐κB activation and IL‐8 secretion. A) HEK‐Blue hTLR2 cells were pre‐incubated with CU‐CPT22 or compounds 1 – 6 and 9 – 11 for 1 h and then stimulated additionally with TLR2/1 agonist Pam 3 CSK 4 (10 ng/mL) or TLR2/6 agonist Pam 2 CSK 4 (1 ng/mL) for 24 h. B) HEK‐Blue hTLR2 cells were pre‐incubated with increasing concentrations of 4 , 6 , 9 , 10 and then stimulated additionally with Pam 3 CSK 4 or Pam 2 CSK 4 for 24 h. Supernatants were tested for TLR2‐mediated NF‐κB/AP‐1 activity by quantification of SEAP release (OD 640 ). C) THP‐1 macrophages were incubated with CU‐CPT22 (25 μM) or compound 6 for 1 h and afterwards stimulated with Pam 3 CSK 4 (10 ng/mL), Pam 2 CSK 4 (1ng/mL), LPS (10 ng/mL), flagellin (1 μg/mL), CL075 (8 μM) or ODN2006 (5 μM) for 24 h. Supernatants were analyzed for IL‐8 secretion by ELISA. Mean+SD or ±SD ( n =3).

Article Snippet: TLR2 ligands : The synthetic lipopeptides Pam 3 CSK 4 and Pam 2 CSK 4 , lipopolysaccharide from Escherichia coli O111:B4 (LPS‐EB), flagellin from Salmonella typhimurium (FLA‐ST), the thiazoloquinoline compound CL075 and class B CpG oligonucleotide ODN2006 were purchased from Invivogen and the TLR2 antagonist CU‐CPT22 was obtained from Sigma‐Aldrich.

Techniques: Inhibition, Activation Assay, Incubation, Activity Assay, Enzyme-linked Immunosorbent Assay